0

Rapid Microbiology Testing Market by Method, End-user and Geography - Forecast and Analysis 2023-2027

  • Published: Nov 2022
  • Pages: 156
  • SKU: IRTNTR74724
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The rapid microbiology testing market is estimated to grow at a CAGR of 9.31% between 2022 and 2027. The size of the market is forecast to increase by USD 2,487.91 million. The growth of the market depends on serval factors, including the increasing incidence of infectious diseases and cancer, the rise in the geriatric population, and the high prevalence of food-borne diseases.

This report extensively covers market segmentation by method (growth-based, nucleic-acid-based, viability-based, and others), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others), and geography (North America, Asia, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

 What will the Size of the Rapid Microbiology Testing Market be During the Forecast Period?

Rapid Microbiology Testing Market Size

To learn more about this report, Download Report Sample

Parent Market Analysis

Technavio categorizes the global rapid microbiology testing market as a part of the global life science tools and services market. The global life science tools and services market covers products and companies engaged in R and D of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R and D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Rapid Microbiology Testing Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Rapid Microbiology Testing Market Driver 

The increasing incidence of infectious diseases and cancer is the key factor driving the global rapid microbiology testing market growth. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised. A compromised immune system makes the individual susceptible to diseases such as tuberculosis and pneumonia.

There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly during the forecast period.

Key Rapid Microbiology Testing Market Trend

The rise in food safety concerns is the primary trend in the global rapid microbiology testing market. Individual food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come into contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world.

The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, the global rapid microbiology testing market is expected to grow during the forecast period.

Key Rapid Microbiology Testing Market Challenge

The inadequate healthcare services in developing regions is a major challenge to the global rapid microbiology testing market growth. Many people in developing regions such as APAC and MEA do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by a lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as rapid microbiology testing.

The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbial testing and the subsequent treatment of infectious diseases. Hence, the drawbacks of developing countries, such as the prevalence of infectious diseases causing high mortality and morbidity, lack of skilled healthcare personnel and financial resources, and inadequate infrastructure and healthcare systems that are responsive to the needs of society, will hinder the growth of the market during the forecast period.

Key Rapid Microbiology Testing Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Rapid Microbiology Testing Market Share by Geography

Global Rapid Microbiology Testing Market Customer Landscape

Who are the Major Rapid Microbiology Testing Market Vendors?                                 

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

abbott.com - The company offers solutions for rapid microbiology testing that includes a wide range of BACT/ALERT 3D culture media bottles adapted to the type of microbial detection performed.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Becton Dickinson and Co.
  • bioMerieux SA
  • Biosensia Ltd.
  • Bruker Corp.
  • Charles River Laboratories
  • Colifast AS
  • Danaher Corp.
  • Don Whitley Scientific Ltd.
  • Euroclone SpA
  • Gradientech AB
  • Merck KGaA
  • Neogen Corp.
  • Quidel Corp.
  • Rapid Micro Biosystems Inc.
  • rqMicro AG

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Rapid Microbiology Testing Market?

The market share growth of the growth-based segment will be significant during the forecast period. Growth-based rapid microbiological testing differs from traditional culture methods in that it relies on the detection of biochemical or physiological growth indicators rather than visible growth. This generally allows for much faster detection, but it frequently necessitates a brief enrichment stage before microorganisms can be detected, especially in samples with low levels of contamination.

Rapid Microbiology Testing Market Size

Get a glance at the market contribution of various segments  Request a PDF Sample

The growth-based segment was valued at USD 1,492.53 million in 2017 and continued to grow until 2021Growth-based microbiology testing can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of a specific microorganism, or microbial identification. The growth-based microbiology testing segment holds the largest market share in the market due to an increase in the early detection of infectious diseases, and it will continue to dominate the market during the forecast period.

Which are the Key Regions for the Rapid Microbiology Testing Market?

Rapid Microbiology Testing Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

North America is projected to hold a 41% share of the market in 2023. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors in the country offering a wide range of microbial testing products are aiding the growth of the market. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbial testing in the region. 

In 2021, business and industrial activities resumed with the lifting of stringent lockdown restrictions due to the availability of COVID-19 vaccines and the vaccination drives carried out by the governments of different countries, such as the US, Canada, and Mexico. This has resulted in the resumption of rapid microbiology testing with proper safety and precautions in clinics and hospitals, which has further increased the demand for microbiology testing. The rise in various diseases among the population, such as bacterial infection, has been a major factor in the market's growth and expansion. Such elements will fuel the growth of the regional market during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by method, end-user, and region.

  • Method Outlook (USD Million, 2017 - 2027)
    • Growth-based
    • Nucleic-acid based
    • Viability-based
    • Others
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospitals and diagnostic laboratories
    • Pharmaceutical and biotechnology companies
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Austarlia
      • Argentina
      • Rest of the World

Rapid Microbiology Testing Market Scope

Report Coverage

Details

Page number

156

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.31%

Market growth 2023-2027

USD 2,487.91 million

Market structure

Fragmented

YoY growth (%)

9.07

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Rapid Microbiology Testing Market Report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the rapid microbiology testing market size and its contribution of the market in focus to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behavior.
  • Growth of the market industry across North America, Asia, Europe, and Rest of World (ROW).
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of rapid microbiology testing market vendors.

 

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Method
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global rapid microbiology testing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global rapid microbiology testing market 2017 - 2021 ($ million)
    • 4.2 Method Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Method Segment 2017 - 2021 ($ million)
    • 4.3 End-User Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Method

    • 6.1 Market segments
      • Exhibit 30: Chart on Method - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Method - Market share 2022-2027 (%)
    • 6.2 Comparison by Method
      • Exhibit 32: Chart on Comparison by Method
      • Exhibit 33: Data Table on Comparison by Method
    • 6.3 Growth-based - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Growth-based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Growth-based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Growth-based - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Growth-based - Year-over-year growth 2022-2027 (%)
    • 6.4 Nucleic-acid based - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Nucleic-acid based - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Nucleic-acid based - Year-over-year growth 2022-2027 (%)
    • 6.5 Viability-based - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Viability-based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Viability-based - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Viability-based - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Viability-based - Year-over-year growth 2022-2027 (%)
    • 6.6 Others - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Method
      • Exhibit 50: Market opportunity by Method ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 53: Chart on Comparison by End-user
      • Exhibit 54: Data Table on Comparison by End-user
    • 7.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
    • 7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 67: Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 71: Chart on Geographic comparison
      • Exhibit 72: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 109: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 112: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 113: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 114: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 115: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 116: Abbott Laboratories - Overview
              • Exhibit 117: Abbott Laboratories - Business segments
              • Exhibit 118: Abbott Laboratories - Key news
              • Exhibit 119: Abbott Laboratories - Key offerings
              • Exhibit 120: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 121: Becton Dickinson and Co. - Overview
              • Exhibit 122: Becton Dickinson and Co. - Business segments
              • Exhibit 123: Becton Dickinson and Co. - Key news
              • Exhibit 124: Becton Dickinson and Co. - Key offerings
              • Exhibit 125: Becton Dickinson and Co. - Segment focus
            • 12.5 bioMerieux SA
              • Exhibit 126: bioMerieux SA - Overview
              • Exhibit 127: bioMerieux SA - Product / Service
              • Exhibit 128: bioMerieux SA - Key offerings
            • 12.6 Bruker Corp.
              • Exhibit 129: Bruker Corp. - Overview
              • Exhibit 130: Bruker Corp. - Business segments
              • Exhibit 131: Bruker Corp. - Key news
              • Exhibit 132: Bruker Corp. - Key offerings
              • Exhibit 133: Bruker Corp. - Segment focus
            • 12.7 Charles River Laboratories
              • Exhibit 134: Charles River Laboratories - Overview
              • Exhibit 135: Charles River Laboratories - Business segments
              • Exhibit 136: Charles River Laboratories - Key news
              • Exhibit 137: Charles River Laboratories - Key offerings
              • Exhibit 138: Charles River Laboratories - Segment focus
            • 12.8 Danaher Corp.
              • Exhibit 139: Danaher Corp. - Overview
              • Exhibit 140: Danaher Corp. - Business segments
              • Exhibit 141: Danaher Corp. - Key news
              • Exhibit 142: Danaher Corp. - Key offerings
              • Exhibit 143: Danaher Corp. - Segment focus
            • 12.9 Don Whitley Scientific Ltd.
              • Exhibit 144: Don Whitley Scientific Ltd. - Overview
              • Exhibit 145: Don Whitley Scientific Ltd. - Product / Service
              • Exhibit 146: Don Whitley Scientific Ltd. - Key offerings
            • 12.10 Gradientech AB
              • Exhibit 147: Gradientech AB - Overview
              • Exhibit 148: Gradientech AB - Product / Service
              • Exhibit 149: Gradientech AB - Key offerings
            • 12.11 Merck KGaA
              • Exhibit 150: Merck KGaA - Overview
              • Exhibit 151: Merck KGaA - Business segments
              • Exhibit 152: Merck KGaA - Key news
              • Exhibit 153: Merck KGaA - Key offerings
              • Exhibit 154: Merck KGaA - Segment focus
            • 12.12 Neogen Corp.
              • Exhibit 155: Neogen Corp. - Overview
              • Exhibit 156: Neogen Corp. - Business segments
              • Exhibit 157: Neogen Corp. - Key news
              • Exhibit 158: Neogen Corp. - Key offerings
              • Exhibit 159: Neogen Corp. - Segment focus
            • 12.13 Quidel Corp.
              • Exhibit 160: Quidel Corp. - Overview
              • Exhibit 161: Quidel Corp. - Product / Service
              • Exhibit 162: Quidel Corp. - Key offerings
            • 12.14 Rapid Micro Biosystems Inc.
              • Exhibit 163: Rapid Micro Biosystems Inc. - Overview
              • Exhibit 164: Rapid Micro Biosystems Inc. - Product / Service
              • Exhibit 165: Rapid Micro Biosystems Inc. - Key offerings
            • 12.15 rqMicro AG
              • Exhibit 166: rqMicro AG - Overview
              • Exhibit 167: rqMicro AG - Product / Service
              • Exhibit 168: rqMicro AG - Key offerings
            • 12.16 Sartorius AG
              • Exhibit 169: Sartorius AG - Overview
              • Exhibit 170: Sartorius AG - Business segments
              • Exhibit 171: Sartorius AG - Key news
              • Exhibit 172: Sartorius AG - Key offerings
              • Exhibit 173: Sartorius AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 174: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 176: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Rapid Microbiology Testing market growth will increase by $2487.91 million during 2023-2027.
              The rapid microbiology testing market is expected to grow at a CAGR of 9.31% during 2023-2027.
              Technavio has segmented the rapid microbiology testing market by method (Growth-based, Nucleic-acid based, Viability-based, and Others) ,end-user (Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, and Others) , and geography (North America, Asia, Europe, and Rest of World (ROW)).
              Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., Thermo Fisher Scientific Inc. are a few of the key vendors in the rapid microbiology testing market.
              North America will register the highest growth rate of 40.79% among the other regions. Therefore, the rapid microbiology testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the rapid microbiology testing market growth are:
              • Increasing incidence of infectious disease and cancer
              • Rise in food safety concerns
              The rapid microbiology testing market vendors should focus on grabbing business opportunities from the growth-based segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>